Mayo clinic tests urine and blood for kidney cancer clues

NCT ID NCT07243067

Not yet recruiting Diagnosis Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks for protein markers in urine and blood that could help identify different types of kidney cancer without needing a biopsy. Researchers will analyze stored urine samples from 300 people and collect blood before and after kidney removal surgery. The goal is to develop a noninvasive test to classify kidney tumors and predict cancer spread.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple urine or blood test to identify kidney cancer types without a biopsy.
What could go wrong: This is an early lab-based study, not a treatment trial. The markers may not prove accurate enough for clinical use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHROMOPHOBE RENAL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chromophobe renal cell carcinoma kidney cancer nonpapillary renal cell carcinoma papillary renal cell carcinoma renal cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHROMOPHOBE RENAL CELL CARCINOMA CLEAR CELL RENAL CELL CARCINOMA KIDNEY CANCER PAPILLARY RENAL CELL CARCINOMA RENAL CELL CARCINOMA

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.